Oak Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
Oak scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
Oak is a telehealth provider operated by Oak Longevity Holdings Corp., with prescriptions issued through NVP Medical Group and InnovaScript Pharmacy named as its preferred pharmacy. Its GLP-1 menu runs to four routes: compounded semaglutide injections, compounded tirzepatide injections, branded GLP-1 injector pens and oral tablets. Its checkout catalog lists every price up front: compounded semaglutide is $200 a month and tirzepatide $250, with lower rates on a three-month supply billed upfront.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Oak at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $200/mo (starting dose)
- Pricing model
- Scales with dose: higher doses cost more
- What's included
- Medication · Shipping · Coaching
- Availability
- 48 states
- FDA status
- No FDA warning letter on record
How we scored Oak
Each dimension is scored algorithmically from Oak’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $200/mo (starting dose), Oak runs about 12% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), and the first 3 months drops to $133. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.8/10Oak offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience; 4 platform features disclosed.
Trust & Safety15%
8.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
9.0/10Oak is available in 48 states: all but Mississippi, West Virginia.
Support10%
7.9/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Oak review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 48 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $200–$250/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Oak
We walked Oak’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Fill out a quick online health form indicating your goals with a dedicated Care Team.
- 2Doctors and health coaches review and select the medication and plan.
- 3Medication is delivered free within days with tracking.
- Every price is listed in Oak's checkout catalog with nothing entered, though its marketing pages quote other figures: from $119/mo on the homepage, as low as $167/mo on the product page and from $190/month on the weight-loss page.
- Site explicitly states no video call is required.
- Free shipping is repeatedly advertised; approval described as 'same day'.
- The Terms of Use spell out refunds: a full refund if not approved, none once approved and shipped, and a discount payback for ending a multi-month plan early.
- Support is by phone, email or the checkout chatbot; no hours are published.
Oak customer support
- Phone
- 435-244-7757
GLP-1 medications Oak offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Oak offers
Beyond GLP-1s, Oak also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$200/mo month to month (“$250 $200/mo”). Selecting a three-month supply shows “$200 $133/mo”; three-month prescriptions are billed upfront, so $399 for the three months at the starting dose. Oak also advertises the rate with code OAKSAVE200. Oak says each dose step typically adds about $50–$75.
$250/mo month to month (“$300 $250/mo”). Selecting a three-month supply shows “$267 $199/mo”; three-month prescriptions are billed upfront, so $597 for the three months at the starting dose. Oak also advertises the rate with code OAKSAVE200. Oak says each dose step typically adds about $50–$75.
Ready to get started?
Plans and promotions change often, so check Oak's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide and tirzepatide, branded GLP-1 injector pens and oral Wegovy tablets all on one platform
- Every price is listed in the checkout catalog before you enter any personal details
- Names its preferred pharmacy (InnovaScript Pharmacy) and its prescribing group (NVP Medical Group)
- No video call is required for initial approval
- Full refund if a provider does not approve you
- Oral Wegovy is listed at $75 for a four-week supply, below the compounded injection price
Watch-outs
- Prices disagree across Oak's own pages: $119 on the homepage, $167 on the product page and $190 on the weight-loss page
- The product page says all doses cost the same while the checkout says each dose step adds roughly $50 to $75
- Serves every state except West Virginia and Mississippi, but the Terms of Use still describe 45 states
- Checkout says “No Subscriptions,” yet the Terms describe plans that renew until you cancel
- Shipping claims conflict: same-day or overnight on marketing pages, 3 to 15 business days in the checkout FAQ
- Canceling a multi-month plan early means paying back the discount on the months you received
- No refund once you are approved and medication ships; disputes go to binding arbitration in New York under Delaware law
Oak's verdict: a low starting price, with dose costs and fine print to check
Oak (run by Oak Longevity Holdings Corp.) markets one price for every dose. Its checkout, where you pay, says the charge rises as your dose does. Compounded semaglutide starts at $200 a month (starting dose) in Oak's checkout catalog. The cheap tier is compounded, Oak's own pages disagree about price and shipping, and the fine print is unusually strict, so it isn't for everyone.
What Oak charges as your dose goes up
Oak's banner reads "One price · All dosages," and its product page says all doses are the same price. The checkout catalog lists compounded semaglutide at $200 per month (starting dose), with compounded tirzepatide above it. The checkout FAQ says something different from the banner: the final charge depends on the dose the doctor prescribes, and each step up is typically about $50 to $75 more. The checkout wording is the one that counts, because that is the page where you pay. Expect the bill to move as your dose does, and ask Oak for a quote on your target dose before you start. Choosing a three-month supply lowers semaglutide to $133 a month and tirzepatide to $199. Three-month prescriptions are billed upfront, so the starting semaglutide supply is $399 at once. Oak also advertises these rates with the code OAKSAVE200.
This matters because GLP-1 dosing escalates over the first several months, so on a dose-tiered plan the maintenance dose, the one where the medication does most of its work, is also the most expensive. Against a category median of $179, Oak's starting semaglutide rate is competitive. Its price housekeeping is poor, though. The homepage says weight loss from $119 a month, the semaglutide product page says as low as $167, and the weight-loss page says programs start at $190. None of those is a checkout price. The checkout catalog is the only figure attached to a transaction, so if you are comparing Oak against anyone else, price it from there.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 112 programs that publish one.
- Free shipping is included, not an add-on at checkout.
- Free health coaching comes standard with the medication.
- No video call is required, since it's an asynchronous intake form.
- Every price is listed before you sign up: the checkout catalog shows each product's rate without asking for a phone number or ZIP code.
What Oak prescribes and how it reaches you
Oak's weight-loss page lists four routes: compounded semaglutide injections, compounded tirzepatide injections, brand-name injector pens, and Oral Wegovy tablets. The prices above are for the compounded injections. The brand pens are priced separately and cost several times more. Oral Wegovy goes the other way: the catalog lists it at $75 for a four-week supply, below the compounded rate. Prescriptions are issued through NVP Medical Group, P.A. You fill out the online health form, check out, and a licensed provider reviews your information. Approval can come within hours. Oak names InnovaScript Pharmacy as its preferred pharmacy, and shipping is free.
What Oak does well, and where it falls short
Oak's strengths are a low starting price, a full price list you can read before giving any details, and free shipping and coaching bundled in. It does not offer one price across doses: its checkout says each dose step adds about $50 to $75. The bigger problem is consistency. Oak's pages disagree on price, on shipping speed and even on whether you are buying a subscription. The checkout says there are no subscriptions, while the Terms describe plans that renew until you cancel. Marketing pages promise same-day or overnight shipping, but the checkout FAQ says three to fifteen business days.
What customers say
Oak used to have essentially no external review footprint, and that has improved a little. Its claimed Trustpilot profile shows a 4.4 out of 5 'Excellent' rating from 54 reviews as of September 2026, only ten of them in the last twelve months. Trustpilot also flags that the company hasn't replied to negative reviews and hasn't invited customers recently. There's still no BBB listing and no Google business profile, so those 54 reviews are the entire independent picture.
Who should pick Oak, and who should walk
Oak is a good fit if you want compounded semaglutide or tirzepatide at a low starting price, you're comfortable with an injection, and you'd rather skip a live video consult. If you plan to stay on therapy and climb to a maintenance dose, get Oak's quote for that dose first, because the checkout says the price rises with each step. If you'd rather not inject, Wellorithm sells compounded semaglutide and tirzepatide as dissolving tablets as well as shots. The trade-off: it shows prices only after its intake quiz.
Skip Oak if the low compounded price is the draw but you'd end up on a brand pen, which is priced separately and costs far more. Also weigh the fine print. You get a full refund if a provider does not approve you, but nothing once you are approved and the medication ships. Canceling a multi-month plan early means paying back the discount on the months you received. Disputes go to binding arbitration in New York under Delaware law.
Trust, safety, and medical oversight
On the reassuring side: Oak shows a LegitScript seal on its site (it could not be confirmed in LegitScript's own lookup), prescriptions run through a licensed medical group, it names its preferred pharmacy, and there are no FDA warning letters against Oak Longevity Holdings Corp. Compare RxSpan MD's physician-led practice, which publishes its certification number and its four 503A pharmacies and ships to all 50 states. The catch: you pay before a clinician reviews you. On the cautious side, the medication is compounded rather than FDA-approved brand product. Oak says it serves every state except West Virginia and Mississippi, yet its Terms of Use still describe 45 states. None of these are red flags alone, but together with the pricing contradictions they're why Oak's trust score isn't higher. See our scoring methodology for how we weigh these factors.
Bottom line
Oak markets one price for every dose. At $200 a month (starting dose) for semaglutide against a $179 category median, with free shipping and coaching included, the starting price is competitive. But Oak's own checkout says each step up in dose costs about $50 to $75 more, and that is the version written on the page where you pay. Oak is priced well at the starting dose, and the maintenance dose, the one that matters over a year, is a figure you have to request. The quoted prices cover only the compounded injections, three different headline figures sit on Oak's own pages, and the refund and early-cancellation terms are stricter than most. If you are starting out and price-sensitive, consider Oak, and ask for the maintenance-dose price before you commit.
The Bottom Line
Oak scores highest on state availability and ease of access.
Ready to start with Oak?
From $200/mo (starting dose). See current pricing and start your free consultation.
Oak might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Oak
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare Oak vs…
Oak scores8.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
Oak vs Amazon One Medical
Amazon One Medical scores 8.5/10

Oak vs Vytora Health
Vytora Health scores 8.4/10

Oak vs CoreAge Rx
CoreAge Rx scores 8.3/10

Oak vs Collective
Collective scores 8.3/10

Oak vs Found
Found scores 8.3/10
Oak vs EverSlim
EverSlim scores 8.3/10
All 46 Oak comparisons
- Oak vs AgelessRx
- Oak vs altRX
- Oak vs Belle Health
- Oak vs bmiMD
- Oak vs Bodybuilding Health+
- Oak vs Brightmeds
- Oak vs Direct Meds
- Oak vs DudeMeds
- Oak vs Eden
- Oak vs Embody
- Oak vs Enhance MD
- Oak vs EverPrime
- Oak vs Gala
- Oak vs GobyMeds
- Oak vs HealthRX
- Oak vs HumeCare+
- Oak vs Ivim Health
- Oak vs Live Vital
- Oak vs Lttl
- Oak vs Luvo Health
- Oak vs MadeMed
- Oak vs MangoRx
- Oak vs Maximus
- Oak vs MEDGm
- Oak vs MEDVi
- Oak vs Midi Health
- Oak vs NewSelf
- Oak vs PlexusDx
- Oak vs Ro
- Oak vs RxSpan MD
- Oak vs Sesame Care
- Oak vs ShedRx
- Oak vs SkinnyRx
- Oak vs SnagRx
- Oak vs Sprout Health
- Oak vs Strut Health
- Oak vs TMates
- Oak vs TrimRx
- Oak vs Wellorithm
- Oak vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Oak review:
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Oak's current pricing
Plans from $200/mo (starting dose). Start your free consultation to check eligibility and today's price.